Navigation Links
NBTY to Webcast Presentation at Barclays Capital 2009 Retail And Restaurants Conference

RONKONKOMA, N.Y., April 27 /PRNewswire-FirstCall/ -- NBTY, Inc. (NYSE: NTY) (, a leading global manufacturer and marketer of nutritional supplements, today announced that it will web cast the presentation by Harvey Kamil, President and Chief Financial Officer of NBTY, at the Barclays Capital 2009 Retail And Restaurants Conference in New York on Wednesday, April 29, 2009.

The presentation is scheduled to be web cast live on the Company Web site,, on Wednesday, April 29 at 11:00AM Eastern Time.


NBTY is a leading global vertically integrated manufacturer, marketer and distributor of a broad line of high-quality, value-priced nutritional supplements in the United States and throughout the world. Under a number of NBTY and third party brands, the Company offers over 22,000 products, including products marketed by the Company's Nature's Bounty(R) (, Vitamin World(R) (, Puritan's Pride(R) (, Holland & Barrett(R) (, Rexall(R) (, Sundown(R) (, MET-Rx(R) (, Worldwide Sport Nutrition(R) (, American Health(R) (, GNC (UK)(R) (, DeTuinen(R) (, LeNaturiste(TM) (, SISU(R) (, Solgar(R) (, Good 'n' Natural(R) (, Home Health(TM) (, Julian Graves, and Ester-C(R) ( brands. NBTY routinely posts information that may be important to investors on its web site.

    Contact:  Harvey Kamil                              Carl Hymans
              NBTY, Inc.                                G.S. Schwartz & Co.
              President & Chief Financial Officer       212-725-4500

Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Palomar Medical Technologies to Host First Quarter 2009 Financial Results Conference Call and Webcast on April 30, 2009
2. Kendle Announces First Quarter 2009 Earnings Conference Call and Webcast
3. ResMed Announces Conference Call and Webcast to Discuss Third Quarter 2009 Results
4. Watson to Host and Webcast Investment Community Meeting at American Urological Association Annual Meeting
5. Hill-Rom Holdings, Inc. Invites You to Join Its Fiscal 2009 Second Quarter Earnings Webcast
6. Amgen Announces Webcast of 2009 First Quarter Financial Results
7. Mylan Schedules First Quarter 2009 Financial Results Conference Call and Live Webcast
8. Webcast Alert: HCA Healthcare 1st Quarter 2009 Earnings Conference Call
9. ISTA Pharmaceuticals Announces Conference Call and Webcast of First Quarter 2009 Financial Results
10. 2010 Dietary Guidelines Advisory Committee Meeting to Be Webcast April 29th and 30th
11. Johnson & Johnson to Webcast Annual Meeting of Shareholders
Post Your Comments:
(Date:11/27/2015)... ... November 27, 2015 , ... According to an article ... the way that they are handling security in light of the recent terrorist attacks ... in an attempt to stop an attack from reaching U.S. soil. Especially around special ...
(Date:11/27/2015)... ... November 27, 2015 , ... A team of Swiss ... to treat it. Surviving Mesothelioma has just posted the findings on the website. ... Zurich analyzed the cases of 136 mesothelioma patients who were treated with chemotherapy followed ...
(Date:11/27/2015)... ... November 27, 2015 , ... "When ... said an inventor from Hillside, N.J. "Many people catch diseases simply from sitting ... individuals will always be protected from germs." , He developed the patent-pending QUDRATECS ...
(Date:11/27/2015)... ... ... The print component of “Supporting Our Caregivers” is distributed ... Minneapolis, South Florida, with a circulation of approximately 250,000 copies and an estimated ... media strategy and across a network of top news sites and partner media ...
(Date:11/27/2015)... ... ... MPWH, the No.1 Herpes-only dating community in the world, revealed that over 50% of its ... 3.7 billion people under the age of 50 – or 67% of the population - ... estimates of HSV-1 infection . , "The data shocks us highly!" said Michelle Li, ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... THOUSAND OAKS, Calif. , Nov. 25, 2015 /PRNewswire/ ... of a Biologics License Application (BLA) with ... Administration (FDA) for ABP 501, a biosimilar candidate to ... the first adalimumab biosimilar application submitted to the FDA ... biosimilar pathway. Sean E. Harper , M.D., ...
(Date:11/25/2015)... On Tuesday, November 24, 2015, the ... Wright Medical Technology, Inc. for product liability and ... implant device, awarded $11 million in favor of ... and three days of deliberations, the jury found ... designed and unreasonably dangerous, and that Wright Medical ...
(Date:11/25/2015)... -- Allergan plc (NYSE: AGN ) today announced that ... York State Attorney General,s Office to end the ... statutes with the Attorney General over the decision of Forest ... selling the now generic version of memantine immediate release tablets.  ... released its counterclaims against New York , ...
Breaking Medicine Technology: